Crowdonomics
ENGEN BIO

Reg CF · Common Stock · Mar 2021

ClosedReached targetReg CFCommon Equity
via WeFunderView campaign
Raised
$1.2M / $1.1M max
100% of ceiling · target hit day 38
Investors
915
$1.3K avg
Post-money valuation
$9.2M
pre-money + amount raised

Raised over time

Cumulative raisedInvestors
$1.2M$604K$0
9154580
Mar 25, 2021 · openedApr 30, 2022 · last reading
Target ($250K) hit — May 2, 2021, day 38$1.0M raised — Feb 7, 2022Deadline Apr 30, 2022 — 0 days out

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via WeFunder; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2018–FY2019 · hover for source
$0
−$167K
FY2018
$0
−$460K
FY2019
RevenueNet income
Metric
FY2018 reviewed*
FY2019 reviewed*
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$167,422
-$460,440
Taxes paid
$440
$440
Balance sheet
Cash
$2,447
$163,609
Accounts receivable
$0
$0
Total assets
$2,447
$163,609
Short-term debt
$0
$21,934
Long-term debt
$588,743
$556,411
Total liabilities
$588,743
$578,345
Other
Headcount
—
2

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Pre-money$8M
Post-money$9.2M
Price / share$0.586
Shares offered426,622

Offering details

Target$250,000
Max$1,070,000
Min investment$100
OpenedMar 25, 2021
DeadlineApr 30, 2022
ClosedApr 30, 2022
Days active401

Links & provenance

Source: Manual
0001670254-21-000291

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.